echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Five highlights of the latest version of the new coronary pneumonia diagnosis and treatment plan

    Five highlights of the latest version of the new coronary pneumonia diagnosis and treatment plan

    • Last Update: 2022-04-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The new crown pneumonia epidemic is still circulating around the world, and the Omicron strain has become the main epidemic strain
    .
    The latest "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" jointly issued by the National Health Commission and the State Administration of Traditional Chinese Medicine has made new adjustments to the case discovery and reporting procedures, case admission and treatment, and antiviral treatment.
    The content of treatment was revised and improved, and it was clarified that centralized isolation management was implemented for mild cases
    .
     
    Optimize case discovery and reporting procedures
     
    On the basis of nucleic acid detection, the new version of the diagnosis and treatment plan adds antigen detection as a supplement to further improve the ability of early detection of cases
    .
     
    The plan requires that suspected cases or those with positive antigen test results should undergo nucleic acid testing immediately or be transferred to a qualified higher-level medical institution for nucleic acid testing
    .
    Those with a positive nucleic acid test result will be quarantined in a centralized manner or sent to a designated hospital for treatment, and will be reported directly online in accordance with regulations
    .
     
    Li Jinming, deputy director of the National Health Commission's Clinical Testing Center, said that nucleic acid testing is still the "gold standard " for determining new crown infection, and antigen testing cannot replace nucleic acid testing
    .
     
      Categorize and treat cases
     
      According to the opinions reflected in various places, "patients with Omicron variant strains are mainly asymptomatic infections and mild cases, most of them do not require excessive treatment, and all admission to designated hospitals will take up a lot of medical resources" and other opinions, the plan further improved the cases.
    Classified treatment measures
    .
    Mild cases are subject to centralized isolation management, and relevant centralized isolation places cannot isolate inbound personnel, close contacts and other groups at the same time
    .
    During the isolation management period, symptomatic treatment and condition monitoring should be done.
    If the condition worsens, it should be transferred to a designated hospital for treatment; ordinary, severe, and critical cases and cases with severe high-risk factors should be treated in designated hospitals.
    Cases should be admitted to ICU for treatment as soon as possible, and patients with high-risk factors and a tendency to become severely ill should also be admitted to ICU for treatment
    .
     
      Further standardize antiviral therapy
     
      Two specific anti-new coronavirus drugs approved by the State Food and Drug Administration were written into the diagnosis and treatment plan, namely: PF-07321332/ritonavir tablet (Paxlovid) and domestic monoclonal antibody (ambavirumab/romisevir) monoclonal antibody injection)
    .
     
      The content of traditional Chinese medicine treatment has been revised and improved
     
      Relevant experts said that the plan combines the clinical treatment experience of various places, strengthens the application of traditional Chinese medicine non-drug therapy, and increases the content of acupuncture and moxibustion; combined with the characteristics of children's patients, it increases the content of children's traditional Chinese medicine treatment
    .
     
      Adjust the management of release from isolation, discharge standards and precautions afterward
     
      According to reports, relevant domestic research has shown that when the nucleic acid Ct value of the infected person in the recovery period is ≥35, the virus cannot be isolated from the sample, and the close contact has not been found to be infected
    .
     
      Accordingly, the new version of the diagnosis and treatment plan will change the "two consecutive negative nucleic acid tests of respiratory specimens (sampling time interval of at least 24 hours)" in the criteria for release from isolation and discharge to "two consecutive nucleic acid tests for the novel coronavirus N gene and ORF gene Ct" All values ​​≥ 35 (fluorescence quantitative PCR method, the cutoff value is 40, and the sampling time is at least 24 hours apart), or two consecutive new coronavirus nucleic acid tests are negative (fluorescence quantitative PCR method, the cutoff value is less than 35, and the sampling time is at least 24 hours apart) hours)"
    .
     
      In addition, the plan revised "continue to 14-day isolation management and health status monitoring after discharge" to "continue to carry out 7-day home health monitoring after release of isolation management or discharge"
    .
      The new crown pneumonia epidemic is still circulating around the world, and the Omicron strain has become the main epidemic strain
    .
    The latest "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" jointly issued by the National Health Commission and the State Administration of Traditional Chinese Medicine has made new adjustments to the case discovery and reporting procedures, case admission and treatment, and antiviral treatment.
    The content of treatment was revised and improved, and it was clarified that centralized isolation management was implemented for mild cases
    .
     
      Optimize case discovery and reporting procedures
     
      On the basis of nucleic acid detection, the new version of the diagnosis and treatment plan adds antigen detection as a supplement to further improve the ability of early detection of cases
    .
     
      The plan requires that suspected cases or those with positive antigen test results should undergo nucleic acid testing immediately or be transferred to a qualified higher-level medical institution for nucleic acid testing
    .
    Those with a positive nucleic acid test result will be quarantined in a centralized manner or sent to a designated hospital for treatment, and will be reported directly online in accordance with regulations
    .
     
      Li Jinming, deputy director of the National Health Commission's Clinical Testing Center, said that nucleic acid testing is still the "gold standard " for determining new crown infection, and antigen testing cannot replace nucleic acid testing
    .
     
      Categorize and treat cases
     
      According to the opinions reflected in various places, "patients with Omicron variant strains are mainly asymptomatic infections and mild cases, most of them do not require excessive treatment, and all admission to designated hospitals will take up a lot of medical resources" and other opinions, the plan further improved the cases.
    Classified treatment measures
    .
    Mild cases are subject to centralized isolation management, and relevant centralized isolation places cannot isolate inbound personnel, close contacts and other groups at the same time
    .
    During the isolation management period, symptomatic treatment and condition monitoring should be done.
    If the condition worsens, it should be transferred to a designated hospital for treatment; ordinary, severe, and critical cases and cases with severe high-risk factors should be treated in designated hospitals.
    Cases should be admitted to ICU for treatment as soon as possible, and patients with high-risk factors and a tendency to become severely ill should also be admitted to ICU for treatment
    .
     
      Further standardize antiviral therapy
     
      Two specific anti-new coronavirus drugs approved by the State Food and Drug Administration were written into the diagnosis and treatment plan, namely: PF-07321332/ritonavir tablet (Paxlovid) and domestic monoclonal antibody (ambavirumab/romisevir) monoclonal antibody injection)
    .
     
      The content of traditional Chinese medicine treatment has been revised and improved
     
      Relevant experts said that the plan combines the clinical treatment experience of various places, strengthens the application of traditional Chinese medicine non-drug therapy, and increases the content of acupuncture and moxibustion; combined with the characteristics of children's patients, it increases the content of children's traditional Chinese medicine treatment
    .
     
      Adjust the management of release from isolation, discharge standards and precautions afterward
     
      According to reports, relevant domestic research has shown that when the nucleic acid Ct value of the infected person in the recovery period is ≥35, the virus cannot be isolated from the sample, and the close contact has not been found to be infected
    .
     
      Accordingly, the new version of the diagnosis and treatment plan will change the "two consecutive negative nucleic acid tests of respiratory specimens (sampling time interval of at least 24 hours)" in the criteria for release from isolation and discharge to "two consecutive nucleic acid tests for the novel coronavirus N gene and ORF gene Ct" All values ​​≥ 35 (fluorescence quantitative PCR method, the cutoff value is 40, and the sampling time is at least 24 hours apart), or two consecutive new coronavirus nucleic acid tests are negative (fluorescence quantitative PCR method, the cutoff value is less than 35, and the sampling time is at least 24 hours apart) hours)"
    .
     
      In addition, the plan revised "continue to 14-day isolation management and health status monitoring after discharge" to "continue to carry out 7-day home health monitoring after release of isolation management or discharge"
    .
      The new crown pneumonia epidemic is still circulating around the world, and the Omicron strain has become the main epidemic strain
    .
    The latest "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" jointly issued by the National Health Commission and the State Administration of Traditional Chinese Medicine has made new adjustments to the case discovery and reporting procedures, case admission and treatment, and antiviral treatment.
    The content of treatment was revised and improved, and it was clarified that centralized isolation management was implemented for mild cases
    .
     
      Optimize case discovery and reporting procedures
      Optimize case discovery and reporting procedures
     
      On the basis of nucleic acid detection, the new version of the diagnosis and treatment plan adds antigen detection as a supplement to further improve the ability of early detection of cases
    .
     
      The plan requires that suspected cases or those with positive antigen test results should undergo nucleic acid testing immediately or be transferred to a qualified higher-level medical institution for nucleic acid testing
    .
    Those with a positive nucleic acid test result will be quarantined in a centralized manner or sent to a designated hospital for treatment, and will be reported directly online in accordance with regulations
    .
    hospital hospital hospital
     
      Li Jinming, deputy director of the National Health Commission's Clinical Testing Center, said that nucleic acid testing is still the "gold standard " for determining new crown infection, and antigen testing cannot replace nucleic acid testing
    .
    standard standard standard
     
      Categorize and treat cases
      Categorize and treat cases
     
      According to the opinions reflected in various places, "patients with Omicron variant strains are mainly asymptomatic infections and mild cases, most of them do not require excessive treatment, and all admission to designated hospitals will take up a lot of medical resources" and other opinions, the plan further improved the cases.
    Classified treatment measures
    .
    Mild cases are subject to centralized isolation management, and relevant centralized isolation places cannot isolate inbound personnel, close contacts and other groups at the same time
    .
    During the isolation management period, symptomatic treatment and condition monitoring should be done.
    If the condition worsens, it should be transferred to a designated hospital for treatment; ordinary, severe, and critical cases and cases with severe high-risk factors should be treated in designated hospitals.
    Cases should be admitted to ICU for treatment as soon as possible, and patients with high-risk factors and a tendency to become severely ill should also be admitted to ICU for treatment
    .
     
      Further standardize antiviral therapy
      Further standardize antiviral therapy
     
      Two specific anti-new coronavirus drugs approved by the State Food and Drug Administration were written into the diagnosis and treatment plan, namely: PF-07321332/ritonavir tablet (Paxlovid) and domestic monoclonal antibody (ambavirumab/romisevir) monoclonal antibody injection)
    .
     
      The content of traditional Chinese medicine treatment has been revised and improved
      The content of traditional Chinese medicine and traditional Chinese medicine treatment has been revised and improved
     
      Relevant experts said that the plan combines the clinical treatment experience of various places, strengthens the application of traditional Chinese medicine non-drug therapy, and increases the content of acupuncture and moxibustion; combined with the characteristics of children's patients, it increases the content of children's traditional Chinese medicine treatment
    .
    children children children
     
      Adjust the management of release from isolation, discharge standards and precautions afterward
      Adjust the management of release from isolation, discharge standards and precautions afterward
     
      According to reports, relevant domestic research has shown that when the nucleic acid Ct value of the infected person in the recovery period is ≥35, the virus cannot be isolated from the sample, and the close contact has not been found to be infected
    .
     
      Accordingly, the new version of the diagnosis and treatment plan will change the "two consecutive negative nucleic acid tests of respiratory specimens (sampling time interval of at least 24 hours)" in the criteria for release from isolation and discharge to "two consecutive nucleic acid tests for the novel coronavirus N gene and ORF gene Ct" All values ​​≥ 35 (fluorescence quantitative PCR method, the cutoff value is 40, and the sampling time is at least 24 hours apart), or two consecutive new coronavirus nucleic acid tests are negative (fluorescence quantitative PCR method, the cutoff value is less than 35, and the sampling time is at least 24 hours apart) hours)"
    .
     
      In addition, the plan revised "continue to 14-day isolation management and health status monitoring after discharge" to "continue to carry out 7-day home health monitoring after release of isolation management or discharge"
    .
    healthy healthy healthy
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.